173 related articles for article (PubMed ID: 8248084)
21. Glycoxidation: the menace of diabetes and aging.
Vlassara H; Palace MR
Mt Sinai J Med; 2003 Sep; 70(4):232-41. PubMed ID: 12968196
[TBL] [Abstract][Full Text] [Related]
22. Accumulation of Maillard reaction products in skin collagen in diabetes and aging.
Dyer DG; Dunn JA; Thorpe SR; Bailie KE; Lyons TJ; McCance DR; Baynes JW
J Clin Invest; 1993 Jun; 91(6):2463-9. PubMed ID: 8514858
[TBL] [Abstract][Full Text] [Related]
23. Naturally occurring inhibitors against the formation of advanced glycation end-products.
Peng X; Ma J; Chen F; Wang M
Food Funct; 2011 Jun; 2(6):289-301. PubMed ID: 21779567
[TBL] [Abstract][Full Text] [Related]
24. Effect of smoking on risk factors for cardiovascular disease in patients with diabetes mellitus and renal insufficiency.
Schiel R; Franke S; Busch M; Müller A; Fleck C; Müller UA; Braun A; Stein G
Eur J Med Res; 2003 Jul; 8(7):283-91. PubMed ID: 12911864
[TBL] [Abstract][Full Text] [Related]
25. Physicochemical analysis of structural alteration and advanced glycation end products generation during glycation of H2A histone by 3-deoxyglucosone.
Ashraf JM; Ahmad S; Rabbani G; Jan AT; Lee EJ; Khan RH; Choi I
IUBMB Life; 2014 Oct; 66(10):686-93. PubMed ID: 25380060
[TBL] [Abstract][Full Text] [Related]
26. Cross-linking of the extracellular matrix by the maillard reaction in aging and diabetes: an update on "a puzzle nearing resolution".
Monnier VM; Mustata GT; Biemel KL; Reihl O; Lederer MO; Zhenyu D; Sell DR
Ann N Y Acad Sci; 2005 Jun; 1043():533-44. PubMed ID: 16037276
[TBL] [Abstract][Full Text] [Related]
27. Effects of valsartan therapy on protein glycoxidation.
Monacelli F; Poggi A; Storace D; Durante A; Traverso N; Viviani GL; Odetti P
Metabolism; 2006 Dec; 55(12):1619-24. PubMed ID: 17142134
[TBL] [Abstract][Full Text] [Related]
28. Involvement of advanced glycation end-products, pentosidine and N(epsilon)-(carboxymethyl)lysine, in doxorubicin-induced cardiomyopathy in rats.
Moriyama T; Kemi M; Okumura C; Yoshihara K; Horie T
Toxicology; 2010 Jan; 268(1-2):89-97. PubMed ID: 20004697
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy.
Horie K; Miyata T; Maeda K; Miyata S; Sugiyama S; Sakai H; van Ypersole de Strihou C; Monnier VM; Witztum JL; Kurokawa K
J Clin Invest; 1997 Dec; 100(12):2995-3004. PubMed ID: 9399945
[TBL] [Abstract][Full Text] [Related]
30. Unexpected elevation of pentosidine formation in collagen incubated with glucose by low concentrations of the AGE-inhibitor aminoguanidine.
Urios P; Grigorova-Borsos AM; Sternberg M
Diabetologia; 2004 May; 47(5):959-61. PubMed ID: 15170500
[No Abstract] [Full Text] [Related]
31. Oxygen is not required for the browning and crosslinking of protein by pentoses: relevance to Maillard reactions in vivo.
Litchfield JE; Thorpe SR; Baynes JW
Int J Biochem Cell Biol; 1999 Nov; 31(11):1297-305. PubMed ID: 10605822
[TBL] [Abstract][Full Text] [Related]
32. Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects.
Odetti P; Fogarty J; Sell DR; Monnier VM
Diabetes; 1992 Feb; 41(2):153-9. PubMed ID: 1733803
[TBL] [Abstract][Full Text] [Related]
33. Renal accumulation of pentosidine in non-diabetic proteinuria-induced renal damage in rats.
Waanders F; Greven WL; Baynes JW; Thorpe SR; Kramer AB; Nagai R; Sakata N; van Goor H; Navis G
Nephrol Dial Transplant; 2005 Oct; 20(10):2060-70. PubMed ID: 15956058
[TBL] [Abstract][Full Text] [Related]
34. Kinetic analysis of furosine and pentosidine in CAPD patients.
Kumano K; Yokota S; Sakai T; Kobayashi N; Yoshida A; Yoshihara T; Shibata K; Izumi G; Wang H
Adv Perit Dial; 1997; 13():53-7. PubMed ID: 9360651
[TBL] [Abstract][Full Text] [Related]
35. Pentosidine: a molecular marker for the cumulative damage to proteins in diabetes, aging, and uremia.
Sell DR; Nagaraj RH; Grandhee SK; Odetti P; Lapolla A; Fogarty J; Monnier VM
Diabetes Metab Rev; 1991 Dec; 7(4):239-51. PubMed ID: 1813279
[TBL] [Abstract][Full Text] [Related]
36. Lipid glycation and protein glycation in diabetes and atherosclerosis.
Miyazawa T; Nakagawa K; Shimasaki S; Nagai R
Amino Acids; 2012 Apr; 42(4):1163-70. PubMed ID: 20957396
[TBL] [Abstract][Full Text] [Related]
37. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
[TBL] [Abstract][Full Text] [Related]
38. Advanced glycation end-products and the progress of diabetic vascular complications.
Jakus V; Rietbrock N
Physiol Res; 2004; 53(2):131-42. PubMed ID: 15046548
[TBL] [Abstract][Full Text] [Related]
39. Protein crosslinking by the Maillard reaction: dicarbonyl-derived imidazolium crosslinks in aging and diabetes.
Chellan P; Nagaraj RH
Arch Biochem Biophys; 1999 Aug; 368(1):98-104. PubMed ID: 10415116
[TBL] [Abstract][Full Text] [Related]
40. [Advanced glycation end products: A risk factor for human health].
Wautier MP; Tessier FJ; Wautier JL
Ann Pharm Fr; 2014 Nov; 72(6):400-8. PubMed ID: 25438650
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
